Loading clinical trials...
Loading clinical trials...
This is a phase Ib, open-label, dose-validating and safety study of caffeine in neonates with hypoxic-ischemic encephalopathy (HIE) undergoing therapeutic hypothermia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
NCT05514340 · Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, and more
NCT06427642 · Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia, and more
NCT04602325 · Urea Cycle Disorder, Organic Acidemia, and more
NCT05836610 · Hypoxic-Ischemic Encephalopathy, Asphyxia, and more
NCT06429007 · Hypoxic-Ischemic Encephalopathy, HIE, and more
The University of North Carolina at Chapel Hill Newborn Critical Care Center
Chapel Hill, North Carolina
Novant Health New Hanover Regional Medical Center
Wilmington, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions